APA (7th ed.) Citation

Jaffe, G. J., Westby, K., Csaky, K. G., Monés, J., Pearlman, J. A., Patel, S. S., . . . Rezaei, K. A. (2021). C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology (Rochester, Minn.), 128(4), 576. https://doi.org/10.1016/j.ophtha.2020.08.027

Chicago Style (17th ed.) Citation

Jaffe, Glenn J., et al. "C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial." Ophthalmology (Rochester, Minn.) 128, no. 4 (2021): 576. https://doi.org/10.1016/j.ophtha.2020.08.027.

MLA (9th ed.) Citation

Jaffe, Glenn J., et al. "C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial." Ophthalmology (Rochester, Minn.), vol. 128, no. 4, 2021, p. 576, https://doi.org/10.1016/j.ophtha.2020.08.027.